The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy ...
Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who ...
As a result, researchers have explored less invasive options that aim to treat the cancer while preserving quality of life. One such approach is TULSA, which uses real-time MRI guidance to deliver ...
The 2026 European Association of Urology (EAU) annual meeting featured a late-breaking abstracts session and a presentation ...
The 2026 European Association of Urology (EAU) annual meeting featured a plenary prostate cancer session and a presentation by Dr. Renu Eapen discussing the optimal management of de-novo ...
Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...
Koelis, SAS ('Koelis” or the 'Company”, a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer ...
Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.
Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer.
Integrative high-throughput studies identify novel targets and drugs for advanced prostate cancer treatment Prostate cancer, a prevalent malignancy ...
Vanquish uses ultrasound, transurethral and electromagnetically guided thermotherapy to ablate prostate tissue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results